Michael E. Kimerling, MD, MPH
Director, Technical Services Division
Michael Kimerling studied anthropology at the University of North Carolina (Chapel Hill), then studied medicine and subsequently trained in Internal Medicine at the University of Minnesota (Minneapolis). He also has a Masters of Public Health in Epidemiology from the University of Alabama-Birmingham (UAB).
Before joining KNCV Tuberculosis Foundation in April 2015, Michael was a member of the Tuberculosis team at the Bill & Melinda Gates Foundation for seven years, where his focus was on international partnerships and innovation in TB control/uptake of new technologies.
Michael started his career in global health working in refugee medicine and subsequently in Cambodia for MSF Holland-Belgium to rebuild primary health care systems while also focusing on tuberculosis and malaria control. In 1994, he returned to UAB where he became a full Professor of Medicine. He was the Director of UAB’s International Tuberculosis Center, and Principal Investigator/Director of the UAB Coordinating Site of the Gorgas TB Initiative.
Michael has served on many international committees and worked previously as a consultant to WHO and others on tuberculosis in many settings across Asia, Africa and Latin America. He has served as a member of the WHO TB STAG, the Technical Review Panel of the Global Fund, as an executive board member of the Stop TB Partnership Coordinating Board, and as a member of the Core Group of the Drug-Resistant Working Group/WHO.
At KNCV, Michael Kimerling leads the Technical Division, which covers TB program support, research and policy development.